| Target Price | $18.36 |
| Price | $11.00 |
| Potential |
66.91%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Evoke Pharma, Inc. 2026 .
The average Evoke Pharma, Inc. target price is $18.36.
This is
66.91%
register free of charge
$18.90
71.82%
register free of charge
$18.18
65.27%
register free of charge
|
|
| A rating was issued by 6 analysts: 0 Analysts recommend Evoke Pharma, Inc. to buy, 3 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Evoke Pharma, Inc. stock has an average upside potential 2026 of
66.91%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 10.25 | 16.29 |
| 97.88% | 58.95% | |
| Net Margin | -52.20% | -20.24% |
| 65.29% | 61.22% |
3 Analysts have issued a sales forecast Evoke Pharma, Inc. 2025 . The average Evoke Pharma, Inc. sales estimate is
This results in the following potential growth metrics:
3 Evoke Pharma, Inc. Analysts have issued a net profit forecast 2025. The average Evoke Pharma, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.81 | -1.92 |
| 89.95% | 31.67% | |
| P/E | negative | |
| EV/Sales | 0.76 |
3 Analysts have issued a Evoke Pharma, Inc. forecast for earnings per share. The average Evoke Pharma, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Evoke Pharma, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


